Board of Directors

­Gary J. Kurtzman, MD, Chairman of the Board
 
Dr Kurtzman is Managing Director in the Life Sciences Group at Safeguard Scientifics, Inc. (www.safeguard.com) (NYSE: SFE), a provider of growth capital for entrepreneurial and innovative life sciences and technology companies, where he is responsible for identifying and partnering with companies focused on molecular diagnostics, medical devices, regenerative medicine and specialty pharmaceuticals services. As part of Safeguard’s Life Sciences Group, Dr. Kurtzman brings more than 17 years of experience in operations and investments, leveraging his expertise to enable businesses to grow their products and services, as well as to discover new partnering potential. Dr. Kurtzman currently serves on the board of directors for Safeguard Scientifics’ partner companies: Advanced BioHealing, Alverix, Avid Radiopharmaceutics, Molecular Biometrics, NuPathe and Tengion. Gary was previously managing director of BioAdvance, an early stage life sciences investor, and held various positions at Pluvita Corporation, Genovo and Avigen, and Gilead Sciences.
 
Dr. Kurtzman is a board-certified internist with a hematology sub-specialty. He is the author of more than 40 peer reviewed scientific publications, reviews and book chapters and the inventor on 18 issued U.S. patents. He is currently a lecturer in Health Care Management at The Wharton School of the University of Pennsylvania where he teaches bioentrepreneurship. Dr. Kurtzman received his BS from Stanford University and his MD from Washington University and post-doctoral training at the National Heart, Lung and Blood Institute and Stanford University.
 
 
David Tennenhouse, Board of Directors
 
David Tennenhouse joined New Venture Partners and opened its Silicon Valley office in 2007. He is focused on developing relationships with corporate and government-funded R&D teams. David joined New Venture Partners from Amazon.com, where he had been Vice President of Platform Strategy and CEO of its A9.com subsidiary.
 
Prior to Amazon/A9, David was Vice President and Director of Research at Intel Corporation, where he pioneered an “open innovation” approach to corporate research that was, in part, based on his earlier work as DARPA’s Chief Scientist and Director of its Information Technology Office. At both DARPA and Intel, David was involved in the strategic planning and execution of programs related to a wide range of technologies, including networking, wireless communications, computer architecture, distributed computing, machine learning, search / data mining, image processing, robotics, MEMs, healthcare, and nano/bio-technology.
 
Dr. Tennenhouse is a Fellow of the IEEE and has held academic appointments at MIT, in the Department of Electrical Engineering and Computer Science and in the Sloan School of Management. He is currently a Trustee of the International Computer Sciences Institute (ICSI) and a member of the FCC’s Technical Advisory Council and of the Naval Research Advisory Committee. He is also an advisor to Carnegie Mellon University’s School of Computer Science and the Mechanical Engineering Department at UC Berkeley.
 
David holds a B.A.Sc. and M.A.Sc. in Electrical Engineering from the University of Toronto and obtained his Ph.D. at the Computer Laboratory of the University of Cambridge.

 
 
Richard C. Tarbox III, Board of Directors
 
Mr. Tarbox, is a industry veteran with more than 35 years experience in global sourcing, marketing, operations and business development in the healthcare market.  Mr. Tarbox has held numerous executive leadership positions in the healthcare industry, most notably with Quidel Corporation, Thermo Fisher Scientific Inc., Ostex International, Inc., AHSC/Baxter International/Cardinal Health and Marion Laboratories, Inc.
 Mr. Tarbox is a graduate of the University of Washington and the Kellogg School of Management at Northwestern University. He has served on boards of emerging technology companies including, Ostex, DenOptix, Metrika Laboratories, BioSeparations and currently serves on the BOD of ClearData Networks, Inc. He has served the industry as a member of the Health Industry Distributors Association (HIDA) Educational Foundation BOD.